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Abstract
Background: There is a no consensus over the most sensitive and 
practical approach to diagnose Gestational Diabetes Mellitus (GDM). 
The standard 75 grams glucose tolerance test (GTT) is widely practi-
ced to diagnose GDM. However, non-fasting 75-gram Glucose Cha-
llenge Test (GCT) with the 2-hour cutoff value of ≥ 140mg/dL is also 
recommended by some professional bodies. The aim of this study was 
to investigate the sensitivity and specificity of GCT when compared 
to GTT for diagnosing GDM.
Methods: Pregnant women in period of gestation between 24-
28 weeks were recruited by simple random sampling method. Non 
fasting 75g GCTs were performed in all followed by fasting 75g 
GTTs within a week time. International Association of the Diabetes 
and Pregnancy Study Groups (IADPSG) criteria of GTT were used as 
the reference test to diagnose GDM and 2-hour value of GCT was 
compared.
Findings: According to IADPSG criteria, 21.5% (59/274) of pregnant 
women had GDM, in compared to 13.1% (36/274) detected by GCT. 
Sensitivity and specificity of GCT were 40.6% and 94.4% respecti-
vely. The area under the ROC curve for the ability of 2-hour value of 
GCT to predict GDM detected by GTT was 0.758 (SE 0.039). Accor-
ding to GTT values, FBS ≥ 92 mg/dL alone recognized 11.7% (32/274) 
of study sample as having GDM. Additional 9.1% (25/274) and 0.7% 
(2/274) of GDM cases were detected with 1-hour value≥180 mg/dL 
and 2-hour hour value ≥ 153 respectively.
Conclusion: GCT with 2-hour cutoff value ≥ 140mg/dL is not sen-
sitive enough to diagnose GDM recognized by GTT. 
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Background
Gestational diabetes mellitus (GDM) is defined as 
any degree of glucose intolerance with onset or first 
recognition during pregnancy and it is associated 
with increased risk of several adverse perinatal and 
maternal outcomes [1, 2]. Adverse perinatal outco-
mes include neonatal hypoglycemia, macrosomia 
which resulting in an increased risk for shoulder 
dystocia, and the need for neonatal intensive care 
[3]. Maternal complications of GDM include increa-
sed risk of caesarean delivery and pre-eclampsia. 
Furthermore, women with GDM have up to 60% 
risk of developing type 2 diabetes mellitus (T2DM) 
within 5-15 years of delivery, and it has been su-
ggested that children prenatally exposed to a dia-
betic milieu have an increased risk for the develop-
ment of T2DM later in life [3, 4]. There are several 
studies showing a significant reduction of those 
adverse outcomes, if promt & proper interventions 
were taken for early diagnosis and to maintain sa-
tisfactory control of hyperglycaemia in pregnancy [1, 
3]. The landmark study of Hyperglycemia and Ad-
verse Pregnancy Outcome (HAPO) as well as many 
other studies including the Australian Carbohydrate 
Intolerance Study in Pregnant Women (ACHOIS) trial 
had shown maternal hyperglycemia less severe than 
that used to define overt diabetes was related to 
clinically important perinatal disorders or problems 
and that their effects can be reduced by means of 
treatment [5] [6]. Therefore, the methods used in 
the diagnosis of GDM should have higher sensitivity 
to detect even milder cases of GDM. 
There is a lack of international consistency with 
regard to the most sensitive and practical approach 
to diagnose GDM. While a 75-gram glucose tole-
rance test (GTT) is commonly employed, glucose 
challenge test (GCT) with different cutoff values is 
also widely used throughout the world. 
Based on the result of HAPO study, a one-step 
approach using a 75-g 2-h GTT with new diagnos-
tic criteria has been recommended by International 
Association of the Diabetes and Pregnancy Study 
Groups (IADPSG) [6] and these new criteria have 
been adopted by several societies, including the 
American Diabetes Association and the Endocrine 
Societies [3, 7]. Other methods used in GDM diag-
nosis include two step method with combination 
of GCT and GTT. In this method, GCT is performed 
in all pregnant women and GTT only for those 
with positive GCT. Even though this method is wi-
dely accepted as the best method, complexity of 
the procedure is a limiting factor. An alternative 
method has been proposed by the World Health 
Organization (WHO) using a 2-h 75 g GTT, with 
a threshold plasma glucose concentration of grea-
ter than 140mg/dL or 7.8 mmol/L at 120 min [7]. 
A number of studies have documented that the 
treatment of gestational diabetes as defined by 
WHO criterion reduced serious perinatal morbidi-
ty and also improved the woman's health-related 
quality of life [8]. Diabetes in Pregnancy Study 
Group India (DIPSI) diagnostic criterion of 2-h PG 
≥ 7.8mmol/L with 75 g oral glucose load is a mo-
dified version of WHO, in that the WHO procedure 
requires women to be in the fasting state, whereas 
DIPSI procedure is performed in the fasting/non-
fasting state irrespective of the last meal timing. 
Several studies conducted in India have shown it 
to be effective [8, 9].
Sri Lankan College of Obstetricians & Gyneco-
logists (SCOG) recommendation on GDM scree-
ning and diagnosis is similar to DIPSI and inclu-
de 75-gram GCT with cutoff value of 140mg/
dL irrespective of fasting state [10]. Even though 
there are advantages such as simplicity and easy 
to perform as it doesn’t require pregnant women 
to be in fasting, this method has not been vali-
dated with gold standard for local population. 
Hence, this prospective study was undertaken to 
ascertain the validity of GCT with cutoff value 
of 7.8 mmol/L (140 mg/dL) to diagnose GDM in 
pregnant women in Sri Lanka.
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Method
Study design 
This study was conducted as a clinic based cross 
sectional study in a Tertiary Hospital, in Sri lanka. 
The study was commenced after the approval of the 
institutional ethics committee, Faculty of Medicine, 
Galle, Sri Lanka. The minimum sample size requi-
red for the study was 139 pregnant women and 
was calculated based on the estimated prevalence 
of GDM in Sri Lanka as 10 % with an absolute 
precision of 5% in an infinite population. However, 
the prevalence of GDM is reported to be as high as 
22% with the new diagnostic criteria in a previous 
single center study in Sri Lanka [11]. Therefore, 296 
pregnant women in 24 to 28 weeks of gestation 
were recruited by simple random sampling method. 
All women who consented for the study were 
subjected to non-fasting 75-gram GCT on the day 
of recruitment. All of them were invited for the 
standard 75-gram oral glucose tolerance test (GTT) 
within a week of recruitment. GTTs were perfor-
med after an overnight fast of at least 8 hours and 
not exceeding 14 hours, and following at least 3 
days of unrestricted carbohydrates (>150g per day) 
and exercise as per WHO guidelines. Two medically 
qualified investigators collected data using an in-
terviewer administered questionnaire. The details 
including age, height, weight, history of diabetes 
in the family, history of GDM in previous pregnancy, 
history of previous delivery of large babies, socio-
economic status were obtained using this ques-
tionnaire. Participant provided data were confirmed 
using pregnancy records, previous medical records 
and hospital records. The body mass index (BMI) of 
the subjects was calculated using the height and 
weight. Blood pressures of all the women were re-
corded. Collection of blood sample was carried out 
by qualified medical laboratory technicians using 
standard protocols. All laboratory tests were qua-
lity controlled and abnormal results were repeated 
and confirmed. Plasma glucose measurements were 
carried out with an automated analyser using the 
glucose oxidase enzymatic calorimetric assay.
GDM was diagnosed according to standard 
IADPSG (international Association of the Diabetes 
and Pregnancy Study Groups) criteria and the diag-
nosis is made when any of the following three 75g 
2 hour OGTT thresholds are met or exceeded: Fas-
ting 92mg/dL, one hour ≥ 180 mg/dL, two hours 
≥ 153 mg/dL. 
Statistical analysis
To compare the mean values between the groups 
independent t-test was used and for proportions, 
Chi-square test was employed. A receiver opera-
ting characteristics (ROC) curve was constructed 
to test the ability of the 2-hour value of GCT to 
identify patients with a diagnosis of GDM and to 
determine the best cutoff value in predicting a 
GDM diagnosis in our population. P-value < 0.05 
was considered statistically significant. Data analy-
sis was done using statistical package for social 
science (SPSS) version 20.
Ethical considerations
Ethical clearance was obtained from ethical review 
committee of Faculty of Medicine, University of 
Ruhuna. A written consent was obtained from all 
pregnant women after detailed written and ver-
bal explanation about the study. Pregnant women 
found to have GDM were referred to antenatal clinic 
for treatment and follow up. 
Results
Of the total of 296 women recruited, 15 didn’t come 
for GTT and 07 could not complete the test due to 
nausea and vomiting. Table 1 shows the baseline 
characteristics of the 274 women who completed 
the study. On average, pregnant women were rela-
tively old with mean age of 31.4±6.7 years and of 
average pre-conception BMI (21.7±4.6 kg/m2). The 
differences of the baseline characteristics between 




Vol. 8 No. 93
doi: 10.3823/1692
This article is available at: www.intarchmed.com and www.medbrary.com 4
subjects with and without GDM (based on IADPSG 
criteria) and GCT ≥ 140 and <140 were shown in 
table 1. 
Being overweight according to pre-conception 
BMI (39.3%) and age over 35 years (39.6%) were 
the two most frequently detected risk factors for 
GDM among the participants in this study. Past 
history of GDM was reported in 3.3% and 30.5% 
had a first degree relative with diabetes mellitus. 
Prevalence of the risk factors for GDM within the 
study population is shown in Table 2. 
According to IADPSG criteria of the 75-gram GTT, 
21.5% (59/274) subjects in the sample were diag-
nosed to have GDM; however, only 13.1% (36/274) 
were detected to have GDM with GCT using 2-hour 
cutoff value ≥ 140 mg/dl. Out of the 36 cases de-
tected by 2-hour value ≥140 mg/dl, 12 women were 
found to have normal GTT (false positive). Thus, only 
24 cases of GDM were diagnosed by GCT with 
2-hour value of ≥ 140 mg/dL, giving the sensitivity 
of 40.6% and specificity of 94.4%. Close to 60% 
(35/59) of patients with true GDM were missed with 
GCT.
When the non-fasting 2-hour cutoff value of GCT 
is increased to ≥ 152 mg/dL (the cutoff value used 
in IADPSG criteria), the detection rate of GDM drop-
ped to 5.8% (16/274). Furthermore, out of three 
glucose test of GTT, 1-hour value has the highest 
sensitivity in detecting GDM followed by FBS (Table 
3 & figure 1). FBS ≥ 92 mg/dL recognized 11.6% 
(32/274) of study sample as having GDM. Additional 
of 9.1% (25/274) and 0.7% (2/274) of GDM cases 
Table 1. Baseline characteristics between subjects with and without GDM.
GCT≥140 GCT<140 with GDM* without GDM*
Age in years <20 2 11 2 11
20-30 9 77 8 78
>30 24 151 49 126
Parity 1 11 72 12 71
2 8 69 18 59
≥3 16 98 29 85
POG1 26.8+/-3.9 25.9+/-4.7 25.5+/-4.7 26.1+/-4.4
BMI <18 4 47 8 43
18-24.9 20 149 35 134
25-29.9 10 35 15 30
>30 1 8 1 8
Past history of GDM 3 6 4 5
Family history of GDM 17 66 23 60
Past history of macrosomia 6 28 8 26
1Data are means +/-SD, *based on IADPSG criteria, GCT≥140mg/dL or ≥ 7.8 mmol/L, GCT<140 mg/dL or <7.8mmol/L. 
POG-period of gestation, BMI-body mass index, GDM-gestational diabetes mellitus, GCT -Glucose Challenge Test.
Table 2.  Prevalence of risk factors in the study po-
pulation.
Risk factor N %
Past history of GDM 09 3.3
Maternal age ≥35 years 108 39.6
Pre conception BMI ≥23 kg/m2 105 39.3
Bad obstetric history- miscarriages, 
still births, IUD etc.) 
65 23.8
Delivering large babies (>3.45kg) 34 12.4
History of T2DM/GDM among first 
degree relatives 
83 30.5
GDM -Gestational Diabetes Mellitus, BMI- Body Mass 
Index, IUD- Intra Uterine Death, T2DM-type 2 diabetes 
mellitus.
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were detected with 1-hour value ≥ 180 mg/dL and 
2-hour hour value ≥ 153 respectively. 
The area under the ROC curve for the ability of 
2-hour value of GCT to predict altered FBS and 1st-
hour value of GTT was 0.758 (SE 0.039) (Fig. 2). The 
best cutoff point of 2-hour value to predict abnor-
mal FBS and 1st-hour values occurred at 120 mg/
dL (sensitivity of 64.9%, the specificity 76.5%) (Fig. 
2). If the cutoff 2-hour value of GCT is increased to 
140mg/dL, sensitivity dropped 37% and specificity 
increased to 96% and this is a clear indication that 
GCT with cutoff 2-hour value of 140 is not sensiti-
ve enough to diagnose GDM in compared to gold 
standard GTT (Fig 2). 
The distribution of 2-hour glucose of GCT in 
women with GDM (n = 59) and without GDM 
(n = 215) is shown in Figure 3. Of note, there was 
considerable overlap in the distribution of 2-hour 
value between these two patient populations. This 
probably indicates that there was no clear thres-
hold level of 2-hour glucose that can be used to 
identify GDM. 
Table 4.  Number of patients with GDM diagnosed 
by FBS, 1st hour value and 2nd hour value 
of GTT.
GDM No GDM sensitivity
FBS* 32 242 11.6%
1st hour value* 37 237 13.5%
2nd hour value* 16 258 5.8%
With all 03* 59 215 21.5%
*Based on IADPSG (International Association of the 
Diabetes and Pregnancy Study Groups) criteria.
Table 3.  Comparison of GCT with GTT using IADPSG 
criteria in diagnosing GDM.
GCT≥140 mg/dL
GTT using IADPSG criteria 
as gold standard Total
Positive Negative
Positive 24 12 36
Negative 35 203 238
Total 59 215 274
GTT-Glucose tolerance test, GCT -Glucose Challenge Test, 
GDM -Gestational Diabetes Mellitus, IADPSG- International 
Association of the Diabetes and Pregnancy Study Groups.
Figure 1:  Number of patients with GDM diagnosed 
by FBS (fasting blood glucose), 1st H (1st 
hour value of GTT, 2nd H (2nd hour value 
of GTT) based on IADPSG criteria.
Figure 2:  ROC curve of 2-hour value to predict ab-
normal FBS and 1-hour value.
Figure 3:  Histogram showing the distribution of 
2-hour glucose level of GCT in women 
with GDM and without GDM.
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Discussion
Number of studies have shown the value of fasting 
Glucose Challenge Test (GCT) with a cutoff value of 
140 mg/dl in diagnosing GDM [1, 8, 12, 13]. Pro-
fessional organizations including Diabetes in Preg-
nancy Study Group of India (DIPSI) and Sri Lankan 
College of Obstetricians & Gynecologists (SCOG) 
have recommended non fasting GCT to diagnose 
GDM based studies carried out in India [9, 10, 14]. 
However, in these studies GCT was not compared 
with standard GTT and the cutoff value was justi-
fied on the basis of equal prevalence macrosomia in 
GDM group and non GDM group. Equal prevalence 
is thought to be due to appropriate recognition and 
treatment of GDM cases in these studies. However, 
prevalence of macrosomia as the surrogate marker 
to diagnose GDM is not accurate as many factors 
including success of the treatment can confound 
the prevalence of macrosomia. There are other stu-
dies showing poor sensitivity of GCT in diagnosing 
GDM [15, 16]. In a recent study done in Indian eth-
nicity had shown very low sensitivity of non- fasting 
GCT when compared to IADPSG criteria (sensitivity 
22.6 %, specificity 97.8 %) [17]. Other studies done 
in South Asian ethnicity as well as in Caucasians 
too had revealed poor sensitivity of 50-gram and 
75-gram GCT [15, 18, 19]. 
Results of our study clearly indicated that the 
non-fasting GCT had a poor sensitivity (40.6%) 
when compared to GTT with IAPDSG criteria. Even 
though sensitivity of GCT in our study is slightly 
better when compared to the study conducted by 
Mohan V et al, the sensitivity of 40% is far below 
the acceptable limit to use as a screening tool. 
GCT would not only miss around 60% of cases, 
but it would falsely diagnose 33% cases as having 
GDM (false positive rate of 33%, 12/36). All this 
33% of cases detected as GDM will unnecessa-
rily undergo more investigations and intervention 
including dietary modification. Magnitude of re-
commending and using wrong test can be un-
derstood if we look at the prevalence of GDM. A 
previous study conducted in a tertiary care center 
showed alarmingly high prevalence of GDM (22%) 
among pregnant women in Sri Lanka. If GCT is 
used in a Tertiary care Hospital which has delivery 
rate of 1000/per month it would miss around 132 
GDM cases per month. 
The main reason for recommending GCT over 
GTT is the simplicity of non-fasting GCT. Advoca-
tors of non-fasting GCT believe that GTT is too 
complex to perform in the antenatal clinic setting 
and also would result in significant low turnover 
as it require pregnant women to be overnight fast. 
However our study as well as previous studies had 
shown that pregnant women had good compliance 
with GTT when motivated [17]. 
Our study has clearly shown 1-hour value of GTT 
was better target than the 2 hour value. Similar fin-
ding was observed in the HAPO study and shown 
that when adjusted for confounders, the 1-hour 
plasma glucose level remained a better predictor 
of primary outcome. In HAPO study FBS ≥ 92 mg/
dl alone recognized 8.3% of the HAPO popula-
tion as having GDM. Adding the 1 hour threshold 
of 180 mg/dl identified an additional 5.7% of the 
population who did not have an elevated fasting 
value and adding the 2 hour threshold of 153 mg/
dl identified an additional 2.1% of the population 
[20]. The finding of HAPO study had indicated that 
targeting 2-hour value after glucose load was not 
the best option. Our findings were also similar to 
the finding of HAPO study. In our study FBS ≥ 92 
mg/dL recognized 11.6% (32/274) of study sample 
as having GDM. Additional of 9.1% (25/274) and 
0.7% (2/274) of GDM cases were detected with 
1-hour value ≥ 180 mg/dL and 2-hour hour value 
≥153 respectively.
Conclusions
The fasting GCT with cutoff value of ≥ 140mg/dL 
lacks adequate sensitivity to diagnose GDM. We 
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recommend fasting GTT to diagnose GDM in all 
pregnant women even though it needs fasting sta-
te and three blood tests. If performing full GTT is 
practically difficult, FBS together with 1-hour plas-
ma glucose after 75 gram glucose load is a good 
alternative.
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